Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men
Open Access
- 9 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 17 (1) , sfad212
Abstract
Background: Hyperkalemia is common among patients with chronic kidney disease (CKD) but there is scarce information on differential risk factors and outcomes for men and women. For instance, smoking has been suggested to be a risk factor for hyperkalemia, but specific analysis of the sex-specific impact of smoking on hyperkalemia in CKD is lacking. Methods: We studied serum potassium levels in 2891 participants from the NEFRONA cohort: 483 controls (47% women) and 2408 CKD patients (38% women) without prior cardiovascular disease (CVD), assessing whether smoking is a risk factor for hyperkalemia, and if hyperkalemia is associated with outcomes separately for men and women. Results: Median potassium levels and prevalence of hypo and hyperkalemia were higher in CKD participants than in controls. Serum potassium levels were higher and hyperkalemia and severe hyperkalemia more prevalent in men than in women with non-dialysis CKD (G3–G5). The highest prevalence of hyperkalemia for each gender was found in CKD G4-G5 and hemodialysis patients for men (46%) and in hemodialysis (54%) for women. Gender-specific etiological multivariate analysis identified current smoking as a risk factor for hyperkalemia only in men. Hyperkalemia was independently associated with stopping RAASi, an outcome which was more common in women. Hyperkalemia was also associated to higher risk of cardiovascular events within 4 years in men. In conclusion, hyperkalemia is common among men and women with CKD, but the prevalence, risk factors and outcomes may differ by gender. Specifically, current smoking is a driver of hyperkalemia in men.Keywords
Funding Information
- FEDER (PI22/00050, ERA-PerMed-JTC2018)
- Instituto de Salud Carlos III (RD21/0005/0001)
- European Union (PMP21/00109)
This publication has 34 references indexed in Scilit:
- Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a differenceAtherosclerosis, 2015
- Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank studyBMJ Open, 2014
- Severe hyperkalemia requiring hospitalization: predictors of mortalityCritical Care, 2012
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort studyBMC Nephrology, 2010
- Serum Potassium and Outcomes in CKDClinical Journal of the American Society of Nephrology, 2010
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney DiseaseArchives of internal medicine (1960), 2009
- Confounding: What it is and how to deal with itKidney International, 2008
- An evaluation of risk factors for adverse drug events associated with angiotensin‐converting enzyme inhibitorsJournal of Evaluation in Clinical Practice, 2004
- New Guidelines for Potassium Replacement in Clinical PracticeArchives of internal medicine (1960), 2000
- EFFECT OF NICOTINE ON SERUM POTASSIUM AND BLOOD GLUCOSEThe Japanese Journal of Pharmacology, 1965